Technical Stock Pick: Should you buy this FY24 multibagger pharma stock after recent dip?

Aurobindo Pharma, part of the pharma space, has rallied more than 100% in FY24 but found some resistance above Rs 1,100 levels in January 2024. The stock underwent price wise correction since January 2024 and is now showing signs of bottoming out which suggests that bulls are ready to take the charge again. Short-term traders … Read more

Selective in pharma and capital goods; will move to overweight in IT on weakness: Trideep Bhattacharya

Trideep Bhattacharya, CIO, Edelweiss MF, says: “It will probably take the next year for that improvement to come through. But the valuations over the next one or two quarters would be such that they may be good to add. On net balance, we were underweight on IT by about 300 bps at the end of … Read more